ReviewCurrent oncology (Toronto, Ont.)2025

Optimal Use of Bispecific Antibodies for the Treatment of Diffuse Large B-Cell Lymphoma in Canada.

Isabelle Fleury et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.